SpletProstate Cancer Working Group 3 PCWG3(2016) ・骨転移の拡がりを評価する定量的な測定法 日本(JP) 骨転移診療ガイドライン(2015) 画像診断ガイドライン(2016) 前立腺癌診療ガイドライン(2016) ・骨転移の可能性を伴う病巣の定量的方法 http://www.cug.top/column/417/
前列腺癌阿比特龙耐药后,恩杂鲁胺联合免疫治疗有效 - 知乎
Splet10. maj 2024 · The clinical PCWG3 subtype was determined for PET versus CI by 3 masked readers. Results: Sixty-seven patients were included, and PSMA PET led to up-staging in 15% (10/67) of patients; of these, 6 of 10 (60%) had nonmetastatic CRPC on CI. PSMA PET resulted in down-staging in 15% (10/67) of patients. Splet13. feb. 2024 · 二、实施操作 1.患者评估 前列腺癌患者在确定ABI治疗方案前均需完成对患者身体和疾病基线状态的准确评估,即病史评估、ECOG评分、血液指标、磁共振成像(MRI)、骨显像及CT等;如条件允许可考虑采用正电子发射断层显像/X线计算机体层成像(PET/CT)前列腺特异性膜抗原-PETCT(PSMA-PET/CT)、磁共振全身成像(whole … theft fraud
Trial Design and Objectives for Castration-Resistant Prostate …
SpletLymph nodes: PCWG3 endorses RECIST 1.1 guidelines For nodal metastasis, clarify if local regional (pelvic only) or extrapelvic (RP, mediastinal, etc) because this has prognostic implications. J Clin Oncol. 2016 Apr 20;34(12):1402-18. Quiz Intro PCWG3 Baseline Progression Bone Quiz Splet22. feb. 2016 · PCWG3 retains the PCWG2 recommendations with modifications that include developing, recording, and validating measures of disease burden. Imaging of the … Splet在2016年更新发布的PCWG3中,推荐确诊CRPC的前列腺特异性抗原(prostate-specific antigen,PSA)阈值由PCWG2中的2.0 ng/ml下调为1.0 ng/ml,这一修订虽然细微但意义深远 。本文从历次PCWG更新的角度,解读其背后的原因及对临床实践的影响。 theft from a motor vehicle offence